Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Nemaura Med Inc (NMRD)

Nemaura Med Inc (NMRD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 2,196
  • Shares Outstanding, K 28,899
  • Annual Sales, $ 80 K
  • Annual Income, $ -14,140 K
  • 60-Month Beta -0.06
  • Price/Sales 1,158.14
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade NMRD with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.50
  • Most Recent Earnings $-0.12 on 02/12/24
  • Latest Earnings Date 02/23/24
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Options Overview Details

View History
  • Implied Volatility 0.00% ( unch)
  • Historical Volatility 114.63%
  • IV Percentile 0%
  • IV Rank N/A
  • IV High 0.00% on N/A
  • IV Low 0.00% on N/A
  • Put/Call Vol Ratio N/A
  • Today's Volume N/A
  • Volume Avg (30-Day) N/A
  • Put/Call OI Ratio N/A
  • Today's Open Interest N/A
  • Open Int (30-Day) N/A

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0710 +2.82%
on 04/03/24
0.0990 -26.26%
on 04/04/24
-0.0070 (-8.75%)
since 03/18/24
3-Month
0.0710 +2.82%
on 04/03/24
0.1280 -42.97%
on 02/22/24
-0.0050 (-6.41%)
since 01/18/24
52-Week
0.0680 +7.35%
on 01/05/24
1.2500 -94.16%
on 07/05/23
-0.7820 (-91.46%)
since 04/18/23

Most Recent Stories

More News
Wearable Devices and IoT Revolutionize Healthcare Monitoring and Weight Management

/PRNewswire/ -- Among the many technologies that are now being integrated with healthcare systems are wearable devices. In effect, medical device manufacturers...

NMRD : 0.0730 (-3.95%)
PLNT : 58.63 (-1.21%)
XPOF : 13.15 (-0.23%)
NVO : 122.81 (-1.38%)
ABT : 104.92 (-0.93%)
Weight-loss Programs Level Up With Smart Wearable Devices

/PRNewswire/ -- The wearable technology market has evolved in recent years into a major tech segment, in large part thanks to consumer market growth which is...

NMRD : 0.0730 (-3.95%)
PLNT : 58.63 (-1.21%)
WW : 1.8300 (+2.81%)
GRMN : 140.46 (-0.43%)
IRTC : 113.09 (+1.44%)
Nemaura Medical, Inc. (NMRD) Reports Q3 Loss, Lags Revenue Estimates

Nemaura Medical, Inc. (NMRD) delivered earnings and revenue surprises of 61.11% and 98.50%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?...

NMRD : 0.0730 (-3.95%)
AXDX : 0.7500 (+1.83%)
Nemaura Medical Receives First Purchase Order from U.S. Health Provider HealthFleet

Nemaura Medical, Inc. (NASDAQ: NMRD)(“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing non-invasive wearable sensors and supporting personalized...

NMRD : 0.0730 (-3.95%)
Nemaura Medical Reports Initial Patient Data from UK NHS Miboko Study that Demonstrates Weight Loss in 100% of Participants

Nemaura Medical, Inc. (NASDAQ: NMRD)(“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing non-invasive wearable sensors and supporting personalized...

NMRD : 0.0730 (-3.95%)
Nemaura Medical, Inc. (NMRD) Reports Q2 Loss, Misses Revenue Estimates

Nemaura Medical, Inc. (NMRD) delivered earnings and revenue surprises of 0% and 75.33%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

NMRD : 0.0730 (-3.95%)
QTNT : 0.3800 (+2.73%)
Nemaura (NASDAQ: NMRD) to Participate at MicroCap Rodeo Windy City Roundup

Nemaura Medical (NASDAQ: NMRD), a medical technology company focused on developing and commercializing a daily disposable, wearable glucose sensor and supporting personalized lifestyle coaching programs,...

NMRD : 0.0730 (-3.95%)
Cutting Edge Medical Devices Offer Innovative Options for Diabetics

/PRNewswire/ -- In the modern technologically-driven healthcare landscape, the business model of medical device companies has evolved from device makers to...

ABT : 104.92 (-0.93%)
NMRD : 0.0730 (-3.95%)
DXCM : 134.50 (+0.48%)
TNDM : 31.26 (-1.54%)
PODD : 166.70 (+0.26%)
Nemaura Medical (NASDAQ: NMRD) Featured in Bell2Bell Podcast

Nemaura Medical (NASDAQ: NMRD) was featured in the Bell2Bell Podcast, a part of IBN’s (InvestorBrandNetwork) sustained effort to provide specialized content distribution via widespread syndication channels....

NMRD : 0.0730 (-3.95%)
H.C. Wainwright Thinks Nemaura Medical’s Stock is Going to Recover

In a report released today, Yi Chen from H.C. Wainwright reiterated a Buy rating on Nemaura Medical (NMRD – Research Report), with a price target of $12.00. The company's shares closed last Friday at...

NMRD : 0.0730 (-3.95%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Key Turning Points

3rd Resistance Point 0.1167
2nd Resistance Point 0.1073
1st Resistance Point 0.0917
Last Price 0.0730
1st Support Level 0.0667
2nd Support Level 0.0573
3rd Support Level 0.0417

See More

52-Week High 1.2500
Fibonacci 61.8% 0.7985
Fibonacci 50% 0.6590
Fibonacci 38.2% 0.5195
Last Price 0.0730
52-Week Low 0.0680

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar